TOP 10 Advanced internal medicine care in North Haven, Connecticut

Scott Gettinger is a renowned doctor specializing in lung cancer treatment and research, located at 6 Devine Street in North Haven, Connecticut, United States. Dr. Gettinger is internationally recognized for his expertise in immunotherapy and targeted therapy for non-small cell lung cancer. He leads several clinical trials evaluating novel therapies for patients with lung cancer and is dedicated to advancing the field through translational research. His primary interests include understanding mechanisms of sensitivity and resistance to molecularly targeted therapies and immunotherapies. Visit Scott Gettinger for cutting-edge care and innovative treatments in the fight against lung cancer.

Sabrina Browning is a renowned doctor specializing in hematology and oncology, located at 6 Devine Street in North Haven, Connecticut, United States. Dr. Browning received her medical degree from the University of Connecticut School of Medicine and completed her internship and residency at Yale New Haven Hospital. She also served as an Amyloid Fellow at the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center. Dr. Browning is passionate about caring for patients with rare hematologic disorders such as AL amyloidosis and hereditary hemorrhagic telangiectasia (HHT). She is a physician in the Smilow Multiple Myeloma and Gammopathies Programs and is actively involved in clinical research to evaluate new treatments for multiple myeloma, AL amyloidosis, and other hematologic diseases.

Dr. Terri Parker is a renowned medical institution located at 20 York Street in New Haven, Connecticut, United States. Dr. Parker is an Assistant Professor of Medicine at the Yale School of Medicine, specializing in Hematology. With a background in internal medicine and hospice and palliative medicine, Dr. Parker also completed a fellowship in hematology and medical oncology at Yale University School of Medicine. Dr. Parker is currently the assistant medical director at Smilow Cancer Hospital in North Haven and is a member of the protocol review committee at Yale Cancer Center. She is dedicated to evaluating and implementing evidence-based oncology pathways for the benefit of her patients.